CVKD
Cadrenal·NASDAQ
--
--(--)
--
--(--)
3.33 / 10
Netural
Cadrenal Therapeutics' fundamentals are concerning, rated neutral with a 3.3/10 score. Key issues include Days sales outstanding in the second quartile (score 1/3) and PB-ROE in the fourth quartile (score 0/3), indicating potential liquidity and valuation risks. Revenue growth metrics (Total operating revenue YoY +78.47%, Operating revenue YoY +92.66%) provide some optimism, but they are outweighed by negative factors like low interest coverage ratio (15.48%) and negative Cash-MV. The overall view is guarded, supporting a cautious stance.
Analysis Checks(7/10)
Revenue-MV
Value-0.26
Score3/3
Weight24.22%
1M Return10.54%
Value-0.26
Score3/3
Weight24.22%
1M Return10.54%
Days sales outstanding
Value72.55
Score1/3
Weight-2.66%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.66%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight19.33%
1M Return8.45%
Value-0.17
Score2/3
Weight19.33%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.93%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.93%
1M Return-1.11%
Asset-MV
Value-0.50
Score1/3
Weight14.13%
1M Return6.68%
Value-0.50
Score1/3
Weight14.13%
1M Return6.68%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight2.07%
1M Return1.11%
Value78.47
Score2/3
Weight2.07%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight19.31%
1M Return8.45%
Value0.46
Score2/3
Weight19.31%
1M Return8.45%
PB-ROE
Value5.29
Score0/3
Weight5.76%
1M Return2.72%
Value5.29
Score0/3
Weight5.76%
1M Return2.72%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.80%
1M Return0.43%
Value92.66
Score2/3
Weight0.80%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight18.98%
1M Return8.41%
Value-0.07
Score2/3
Weight18.98%
1M Return8.41%
Revenue-MV
Value-0.26
Score3/3
Weight24.22%
1M Return10.54%
Value-0.26
Score3/3
Weight24.22%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value78.47
Score2/3
Weight2.07%
1M Return1.11%
Value78.47
Score2/3
Weight2.07%
1M Return1.11%
Days sales outstanding
Value72.55
Score1/3
Weight-2.66%
1M Return-1.57%
Value72.55
Score1/3
Weight-2.66%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight19.31%
1M Return8.45%
Value0.46
Score2/3
Weight19.31%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight19.33%
1M Return8.45%
Value-0.17
Score2/3
Weight19.33%
1M Return8.45%
PB-ROE
Value5.29
Score0/3
Weight5.76%
1M Return2.72%
Value5.29
Score0/3
Weight5.76%
1M Return2.72%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight-1.93%
1M Return-1.11%
Value15.48
Score2/3
Weight-1.93%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value92.66
Score2/3
Weight0.80%
1M Return0.43%
Value92.66
Score2/3
Weight0.80%
1M Return0.43%
Asset-MV
Value-0.50
Score1/3
Weight14.13%
1M Return6.68%
Value-0.50
Score1/3
Weight14.13%
1M Return6.68%
Cash-MV
Value-0.07
Score2/3
Weight18.98%
1M Return8.41%
Value-0.07
Score2/3
Weight18.98%
1M Return8.41%
Is CVKD undervalued or overvalued?
- CVKD scores 3.33/10 on fundamentals and holds a Fair valuation at present. Backed by its -200.47% ROE, 0.00% net margin, -0.93 P/E ratio, 4.87 P/B ratio, and -46.06% earnings growth, these metrics solidify its Netural investment rating.
